A database of FDA approved therapeutic peptides and proteins
ID1001 | ThPPIDTh1001 | NameLepirudin | Peptide SequenceLVYTDCTESGQNLCLCEGSN Full view | Length65 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandRefludan | CompanyBerlex Labs | Physical AppearanceSterile, white, freeze-dried powder | Route of AdministartionIntravenous infusion | CategoryAntithrombins and Fibrinolytic Agents | TargetProthrombin |
ID1032 | ThPPIDTh1006 | NameBivalirudin | Peptide SequenceFPRPGGGGNGDFEEIPEEYL Full view | Length20 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandAngiomax | CompanyMedicines Co or MDCO | Physical AppearanceWhite lyophilized cake in single-use vials | Route of AdministartionIntravenous infusion | CategoryAntithrombins | TargetProthrombin |
ID1033 | ThPPIDTh1006 | NameBivalirudin | Peptide SequenceFPRPGGGGNGDFEEIPEEYL Full view | Length20 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandAngiox | CompanyThe Medicines Company UK Ltd | Physical AppearancePowder for concentrate for solution | Route of AdministartionInjection | CategoryAntithrombins | TargetProthrombin |
ID1532 | ThPPIDTh1111 | NameDefibrotide | Peptide SequenceN.A. Full view | Length0 | Functional ClassificationIb | DiseaseImmunological | BrandNoravid | Companysanofi-aventis | Physical AppearanceN.A. | Route of AdministartionN.A. | CategoryAntithrombins | TargetAdenosine receptor A1,Adenosine receptor A2a,Adenosine receptor A2b |
ID1549 | ThPPIDTh1118 | NameSulodexide | Peptide SequenceN.A. Full view | Length0 | Functional ClassificationIIIc | DiseaseHormonal/genetic/Hematological/N.A. | BrandSULODEXIDE | CompanySyntex S.A | Physical AppearanceN.A. | Route of AdministartionN.A. | CategoryAntithrombins and Fibrinolytic Agents and Hypoglycemic Agents and Anticoagulants and Hypolipidemic Agents | TargetHeparin cofactor 2,Antithrombin-III |